NLS Pharmaceutics
NLSP
NLSP
7 hedge funds and large institutions have $1.48M invested in NLS Pharmaceutics in 2024 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
7
Holders Change
+2
Holders Change %
+40%
% of All Funds
0.1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
1
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
AC
Armistice Capital
New York
|
$391K |
2 |
Renaissance Technologies
New York
|
$32K |
3 |
XT
XTX Topco
George Town,
Cayman Islands
|
$4.65K |
4 |
Citadel Advisors
Miami,
Florida
|
$3.49K |
Top Sellers
1 |
Wells Fargo
San Francisco,
California
|
$0 |